INDP
IndaptusยทNASDAQ
--
--(--)
--
--(--)
INDP Profile
Indaptus Therapeutics, Inc.
A pharmaceutical company that develops therapy based on the hypothesis that efficient actiation of both innate and adaptive immune cells
3 Columbus Circle, 15th Floor, New York, NY 10019
--
Indaptus Therapeutics, Inc., was incorporated in Delaware on February 24, 2021. The company is a clinical biotechnology company that develops a systemic anticancer and antiviral immunotherapy based on attenuated and inactivated gram-negative bacteria. Its lead drug candidate, Decoy 20, was evaluated in a Phase 1 trial for advanced solid tumors, but further clinical development has been stopped.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
